newsfilter
← Latest News
Business Wire·

Ionis reports first quarter 2026 financial results and highlights progress on key programs

- TRYNGOLZA® (olezarsen) showed increasing demand in FCS driven by strong launch execution – - Olezarsen sNDA accepted by the FDA for Priority Review; sHTG launch preparations on track – – Increasing annual